This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Ariad Pharmaceuticals, Inc., Mitotix, Inc., Ariad Gene Therapeutics, Inc.. Active years: 1999-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 69 
2 out of 16 
1 out of 13 Years Active: 1999-2003
Title: The Innovative Contributions of Maria Isabel Chiu in Immunology
Introduction: Maria Isabel Chiu is a prominent inventor based in Boston, MA, recognized for her significant contributions to the field of immunology. With a remarkable portfolio of six patents, she has made strides in the understanding and application of immunosuppressive therapies.
Latest Patents: Among her latest patents, she has developed innovative immunosuppressant target proteins. This invention encompasses the discovery of novel mammalian-origin proteins that serve as immediate downstream targets for FKBP/rapamycin complexes. The patent details include isolated polypeptides, nucleic acids encoding such proteins, antibodies, as well as various screening methods and diagnostic and therapeutic applications related to these proteins.
Career Highlights: Maria has had a distinguished career in the pharmaceutical industry. She has worked with renowned companies such as Ariad Pharmaceuticals, Inc. and Mitotix, Inc., where she contributed her expertise in drug development and protein research. Her work has been pivotal in advancing therapies that regulate immune responses.
Collaborations: Throughout her career, Maria has collaborated with many talented individuals, including her coworkers Guillaume Cottarel and Vivian Berlin. These collaborations have played a crucial role in fostering innovation and developing new therapeutic strategies within her field.
Conclusion: Maria Isabel Chiu’s innovations in immunology highlight her as a significant figure in the medical research community. Her discoveries and patents continue to pave the way for advancements in immunosuppressive therapies, demonstrating the vital role of inventors like her in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile